On September 3, Ionis Pharmaceuticals fell 5.06% in regular trading, trading at $58.215 USD/share, with Turnover of $98.26 million.
Within the Biotechnology sector where Ionis Pharmaceuticals belongs, individual stocks showed broad divergence. Among individual stocks, Moderna down 4.43%, Ultragenyx Pharmaceutical down 44.33%, AbbVie down 0.34%, Hyperliquid Strategies Inc up 7.76%, Amgen up 0.19%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)